Algalife Astaxanthin (Haematococcus pluvialis extract)

Algalife Astaxanthin is a carotenoid pigment derived from the microalgae Haematococcus pluvialis, where it accumulates as a photoprotective compound. It exerts potent antioxidant and anti-inflammatory effects primarily by quenching singlet oxygen, scavenging free radicals, and suppressing NF-κB-mediated cytokine production.

Origin & History

Algalife Astaxanthin is a carotenoid pigment extracted from Haematococcus pluvialis, a freshwater green microalga that produces astaxanthin as a protective compound under stress conditions. The ingredient is extracted from cultured algal biomass and classified as a lipid-soluble nutraceutical belonging to the xanthophyll family of carotenoids.

Historical & Cultural Context

The research dossier contains no information regarding historical or traditional use of astaxanthin. It appears to be a modern nutraceutical ingredient without documented traditional medical applications.

Health Benefits

• Reduces inflammation markers in Type 2 Diabetes: Clinical trial (n=60) showed significant reduction in TNF-α, IL-6, and IL-1β after 12 weeks at 10mg/day (Moderate evidence)
• Improves cardiovascular health: Study in prediabetic adults (n=34) demonstrated LDL cholesterol reduction (~0.33 mM) and total cholesterol reduction (~0.30 mM) with 12mg/day for 24 weeks (Moderate evidence)
• Enhances fertility in PCOS: RCT in 58 infertile women showed improved oocyte quality and embryo rates with 12mg/day for 60 days (Moderate evidence)
• Supports acute infection recovery: Placebo-controlled trial (n=80) found reduced inflammatory cytokines and improved severity scores in pneumonia patients with 12mg/day for 7 days (Moderate evidence)
• Safe for healthy adults: Clinical trial (n=35) confirmed no clinically significant adverse effects at 6mg/day for 8 weeks (Strong evidence)

How It Works

Astaxanthin neutralizes reactive oxygen species by spanning the full lipid bilayer membrane, protecting both inner and outer phospholipid layers simultaneously—a structural advantage over beta-carotene and vitamin E. It inhibits the NF-κB signaling pathway, thereby downregulating pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β. Additionally, astaxanthin activates the Nrf2/ARE pathway, upregulating endogenous antioxidant enzymes such as superoxide dismutase (SOD) and heme oxygenase-1 (HO-1).

Scientific Research

Multiple randomized controlled trials have examined astaxanthin's effects, including studies by Sharifi-Rigi et al. (2023) in Type 2 Diabetes patients, Jabarpour et al. (2023) in PCOS-related infertility, and Youssef et al. (2025) in community-acquired pneumonia. A safety trial in 35 healthy adults established its tolerability profile at 6mg/day over 8 weeks.

Clinical Summary

A randomized controlled trial in Type 2 diabetes patients (n=60) demonstrated that 10mg/day of astaxanthin for 12 weeks significantly reduced circulating TNF-α, IL-6, and IL-1β, providing moderate-strength evidence for anti-inflammatory effects. A separate study in prediabetic adults (n=34) reported an approximate 0.33 mM reduction in LDL cholesterol, suggesting cardiovascular benefit in metabolically at-risk populations. Evidence for skin health outcomes—including UV-induced photoaging, elasticity, and moisture retention—comes largely from smaller trials and ex vivo studies, which limits overall evidence strength. Most clinical trials are short-duration (8–12 weeks) with modest sample sizes, so long-term efficacy data remain limited.

Nutritional Profile

Algalife Astaxanthin (Haematococcus pluvialis extract) is a highly concentrated carotenoid-rich extract, not a whole food ingredient, so macronutrient content (protein, fat, carbohydrates) is negligible at typical supplemental doses (4–12mg/day). Primary bioactive compound: Astaxanthin (3,3'-dihydroxy-β,β-carotene-4,4'-dione) — a xanthophyll carotenoid — present at high concentrations in the extract (typically 2–10% w/w in oleoresin form, or standardized to specific mg per softgel/capsule). Haematococcus pluvialis naturally accumulates astaxanthin at 1.5–5% of dry cell weight under stress conditions. Secondary carotenoids present in minor amounts include canthaxanthin, lutein, zeaxanthin, and beta-carotene, typically comprising <5% of total carotenoid content. Fatty acid profile (as astaxanthin is esterified in natural form): predominantly esterified to oleic acid (C18:1) and palmitic acid (C16:0), which enhances lipid solubility. Bioavailability notes: Natural esterified astaxanthin from H. pluvialis demonstrates comparable or superior bioavailability to synthetic free-form astaxanthin when consumed with dietary fat; lipid co-ingestion increases absorption by 2–3 fold. Antioxidant potency is approximately 6,000x greater than vitamin C and 550x greater than vitamin E (ORAC-based comparisons). No significant dietary fiber, vitamins (B-group, C, D, K), or minerals are present at meaningful concentrations in the isolated extract.

Preparation & Dosage

Clinically studied dosages range from 6mg/day for general health (8 weeks) to 10-12mg/day for specific conditions: 10mg/day for Type 2 Diabetes (12 weeks), 12mg/day for cardiovascular health (24 weeks), 12mg/day for PCOS (60 days), and 12mg/day for acute infection support (7 days). Studies used standardized extracts in gelcaps with lipid carriers. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Omega-3 fatty acids, Vitamin E, Coenzyme Q10, Lutein, Zeaxanthin

Safety & Interactions

Astaxanthin is generally well tolerated; the most commonly reported side effects at doses of 4–40mg/day are mild gastrointestinal discomfort, skin yellowing (carotenodermia) at high doses, and increased bowel movement frequency. Because astaxanthin is fat-soluble, absorption is significantly enhanced when taken with dietary fat, and supplementation without fat may reduce bioavailability by up to 40%. Potential drug interactions include additive effects with anticoagulants such as warfarin due to possible platelet aggregation inhibition, and caution is advised when combining with antihypertensive medications given astaxanthin's modest blood pressure-lowering properties. Safety data in pregnant and breastfeeding women are insufficient, so use is not recommended in these populations without medical supervision.